Rallybio
RLYB
49 hedge funds and large institutions have $31.1M invested in Rallybio in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 7 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
0.37% more ownership
Funds ownership: 9.4% → 9.77% (+0.37%)
0% more funds holding
Funds holding: 49 → 49 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
15% less capital invested
Capital invested by funds: $36.5M → $31.1M (-$5.39M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Almitas Capital
Santa Monica,
California
|
+$443K |
| 2 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
+$77.9K |
| 3 |
Renaissance Technologies
New York
|
+$39.4K |
| 4 |
EGM
Engineers Gate Manager
New York
|
+$37.4K |
| 5 |
GVAG
Great Valley Advisor Group
Wilmington,
Delaware
|
+$15.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$575K |
| 2 |
CPX
Canaan Partners XI
Menlo Park,
California
|
-$223K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$108K |
| 4 |
Jane Street
New York
|
-$26.1K |
| 5 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$25.6K |
RLYB Hedge Fund Activity: Q4 2024 in Review
49 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q4 2024, worth a combined $31.1M — down 15% from $36.5M a quarter earlier.
Fund positioning in RLYB was balanced in Q4 2024: 7 funds opened new positions, 7 closed out, 13 added to existing stakes and 10 trimmed.
The largest buyer was Almitas Capital, adding an estimated $443K. The largest seller was Fidelity Investments, cutting an estimated $575K.
- 49 institutional investors held Rallybio (RLYB) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $31.1M of Rallybio stock for Q4 2024, down 15% quarter-over-quarter.
- 7 funds opened new Rallybio positions in Q4 2024 and 7 closed out, a net change of 0 holders.
- The largest Rallybio buyer in Q4 2024 was Almitas Capital, an estimated $443K added.
- The largest Rallybio seller in Q4 2024 was Fidelity Investments, an estimated $575K sold.
Based on aggregated 13F filings for Q4 2024.